Literature DB >> 2621664

Post-puerperal Cu-T insertion: a prospective study.

A R Bhalerao, M C Purandare.   

Abstract

One hundred and sixty eight consecutive women accepting copper T (CuT) intrauterine contraceptive device in the post-puerperal period were studied. Out of them, 63 could be followed after 6 weeks of insertion and 65 after 6 months of insertion. The risk of heavy bleeding, pain in abdomen etc. were no greater than those usually found when interval CuT insertion is carried out. There was no case of uterine perforation leading to migration of CuT. But the expulsion rate was found to be high i.e. 16.4%. CuT is a very useful post-puerperal contraceptive method and should be given more importance in MCH programme.

Entities:  

Keywords:  Acceptor Characteristics; Acceptors; Asia; Behavior; Biology; Bleeding; Clinical Research; Clinical Trials; Contraception; Contraception Failure; Contraceptive Methods; Contraceptive Usage; Developing Countries; Diseases; Family And Household; Family Characteristics; Family Planning; Family Planning Programs; Family Relationships; India; Infections; Insertion; Iud; Iud, Copper Releasing; Lactation; Maternal Physiology; Metrorrhagia; Pain; Pelvic Infections; Physiology; Postpartum Programs; Psychological Factors; Research Methodology; Sex Preference; Signs And Symptoms; Sons; Southern Asia; Surgery; Surgical Error; Treatment; Value Orientation

Mesh:

Year:  1989        PMID: 2621664

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  2 in total

1.  Acceptance rate, probability of follow-up, and expulsion of postpartum intrauterine contraceptive device offered at two primary health centers, North India.

Authors:  Shashi Kant; S Archana; Arvind Kumar Singh; Farhad Ahamed; Partha Haldar
Journal:  J Family Med Prim Care       Date:  2016 Oct-Dec

2.  Post-placental intrauterine device insertion--a five year experience at a tertiary care centre in north India.

Authors:  Manju Shukla; Sabuhi Qureshi
Journal:  Indian J Med Res       Date:  2012-09       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.